Loading...
Docoh

Concert Pharmaceuticals (CNCE)

Utility
Deuterated EPI-743
8 Mar 22
Julie F. Liu, Darren H. Wong
Filed: 18 Nov 16
Utility
Combination of Morphinan Compounds and Antidepressant for the Treatment of Pseudobulbar Affect, Neurological Diseases, Intractable and Chronic Pain and Brain Injury
27 Jan 22
Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt thereof of either of the foregoing, and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing.
Amanda Thomas
Filed: 22 Feb 21
Utility
4-HYDROXYBUTYRIC Acid Analogs
30 Dec 21
This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing.
Roger D. Tung, Adam J. Morgan
Filed: 1 Feb 21
Utility
Novel Deuterated Jak Inhibitor and Uses Thereof
16 Dec 21
I. Robert Silverman, Changhua Liu
Filed: 21 May 21
Utility
Morphinan Compounds
11 Nov 21
This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof.
Roger Tung
Filed: 14 Dec 20
Utility
4-hydroxybutyric acid analogs
2 Nov 21
This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing.
Roger D. Tung
Filed: 10 Jan 20
Utility
Deuterated Derivatives of Ruxolitinib
28 Oct 21
I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
Filed: 10 Dec 20
Utility
Deuterated EPI-743
2 Sep 21
Julie F. Liu, Darren H. Wong
Filed: 18 Nov 16
Utility
Deuterated Analogs of D-beta-hydroxybutyric Acid and Uses Thereof
14 Jan 21
Roger D. Tung, I. Robert Silverman, Naeem Yusuff
Filed: 21 Sep 20
Utility
Deuterated Analogs of D-serine and Uses Thereof
16 Dec 20
This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.
Dario Doller, Christopher L. Brummel, Julie F. Liu, Roger D. Tung
Filed: 26 May 20
Utility
4-HYDROXYBUTYRIC Acid Analogs
9 Dec 20
This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing.
Roger D. Tung
Filed: 9 Jan 20
Utility
Deuterated Analogs of D-serine and Uses Thereof
25 Nov 20
This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.
Dario Doller, Christopher L. Brummel, Julie F. Liu, Roger D. Tung
Filed: 20 Nov 18
Utility
Deuterated baricitinib
23 Nov 20
Roger D. Tung
Filed: 29 Mar 18
Utility
Deuterated idebenone
23 Nov 20
Roger D. Tung
Filed: 15 May 19
Utility
Morphinan compounds
26 Oct 20
This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof.
Philip B. Graham, I. Robert Silverman
Filed: 25 Jul 19
Utility
Treatment of Hair Loss Disorders with Deuterated Jak Inhibitors
15 Jul 20
Amanda T. Wagner, James V. Cassella, Philip B. Graham, Virginia Braman, Vinita Uttamsingh, Jana Von Hehn, Colleen E. Hamilton
Filed: 4 Dec 19
Utility
Deuterated OTX-015
15 Jun 20
This invention relates to novel thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines, and pharmaceutically acceptable salts thereof.
Scott L. Harbeson, Julie F. Liu
Filed: 26 Apr 16
Utility
Deuterated analogs of D-serine and uses thereof
1 Jun 20
This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.
Dario Doller, Christopher L. Brummel, Julie F. Liu, Roger D. Tung
Filed: 1 Jul 19
Utility
Treatment of hair loss disorders with deuterated JAK inhibitors
17 Feb 20
Amanda T. Wagner, James V. Cassella, Philip B. Graham, Virginia Braman, Vinita Uttamsingh, Jana Von Hehn, Colleen E. Hamilton
Filed: 3 May 17
Utility
Morphinan Compounds
22 Jan 20
This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof.
Philip B. Graham, I. Robert Silverman
Filed: 25 Jul 19
Patents are sorted by USPTO publication date, most recent first